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Abstract
This randomised controlled laboratory study 
demonstrated the residual speed of efficacy of an 
imidacloprid/flumethrin collar (Seresto® , Bayer) 
for the control of ticks (Dermacentor variabilis, 
Amblyomma americanum) at 6 and 12 hours post-
infestation on dogs when compared to oral afox-
olaner (NexGard®, Merial). Dogs were randomised 
by pre-treatment tick counts: Group 1) imidaclo-
prid 10 % (w/w) / flumethrin 4.5 % (w/w) collar, 
2) afoxolaner chewable (dosage 3.1 – 6.2 mg/kg), and 
3) non-treated controls. Ticks (50/species/dog) were 
infested on days 3, 14, 21, and 28; live (attached 
and non-attached) and dead attached ticks were 
counted 6 and 12 hours later. Efficacy against live 
D. variabilis at 6 hours for Group 1 was 95 – 100 % 
and for Group 2 was 38 – 48 %; efficacy at 12 hours 
for Group 1 was 97 – 100 % and for Group 2 was 
27 – 59 %. Efficacy against A. americanum at 
6 hours for Group 1 was 94 – 100 % and for Group 2 
was < 0 – 38 %; efficacy at 12 hours for Group 1 was 
98 – 100 % and for Group 2 was 1 – 40 %. Live and 
total (total live and dead attached) tick counts in 
Group 1 against both tick species were significantly 
lower (p ≤ 0.05) than Group  2 and 3 at all time 
points. The number of live or total ticks on Group 2 
dogs was never significantly lower when com-
pared to the respective number of ticks on Group 3 
(controls). This study demonstrated that an imida-
cloprid/flumethrin collar was highly efficacious 
(94 – 100 %) at repelling and killing ticks on dogs 
at 6 and 12 hours post-infestation and was more 




Dermacentor variabilis and Amblyomma america-
num belong to the Ixodidae family of ticks, also 
known as hard ticks due to their hard dorsal sur-
face or scutum. The two other genera within the 
Ixodidae family that commonly infest dogs in North 
America are Ixodes and Rhipicephalus (Bowman 
2009). Most species, if not all, from these genera 
are 3-host ticks; they feed on 3 different hosts dur-
ing their life cycle (Sonenshine 2013). This feeding 
behavior makes ticks excellent vectors of diseases 
as they may acquire pathogens not only via vertical 
transmission from the adult female (transovarial 
transmission) but also while feeding on different 
hosts as larvae or nymphs (transstadial transmis-
sion) (Bowman 2009).
Tick-borne diseases are an emerging infectious 
threat with ticks acting as the leading source of 
pathogen transmission to animals (Chomel 2011). 
Ticks are capable of transmitting a myriad of 
pathogens, including viruses, protozoa, and bacte-
ria. Specifically, D. variabilis and A. americanum 
can vector Rickettsia rickettsii, the causative agent 
of Rocky Mountain spotted fever, as well as many 
Ehrlichia species (Chomel 2011; Goddard and 
Varela-Stokes 2009). In addition, D. variabilis can 
vector Theileria equi and A. americanum can vec-
tor Rickettsia parkeri and Hepatozoon americanum 
in several countries throughout the world.
It was previously thought that the transmission 
of diseases causing organisms by ticks took over 
24 hours. However, recent research evaluating 
Ehrlichia canis transmission by Rhipicephalus 
sanguineus in dogs revealed that transmission 
can occur as fast as 3 hours (Fourie et al. 2013b). 
Other Rickettssial pathogens are thought to be 
transmitted within 4 – 24 hours and transmission 
of Borrelia burgdorferi, by certain Ixodes species, 
has been documented to occur in less than 24 hours 
(Cook 2015; Nicholson et al. 2010). While trans-
mission times vary depending on the pathogen 
involved, the faster a tick is repelled and/or killed 
the less likely the tick will be able to attach and 
feed, thereby limiting the risk for transmission of 
disease causing organisms. 
The imidacloprid/flumethrin collar (Seresto®, 
Bayer) has been marketed in the United States 
since 2013 with 8 month repel and kill efficacy 
against fleas (Ctenocephalides felis) and ticks 
(Ixodes scapularis, D. variabilis, R. sanguineus, and 
A. americanum), one month efficacy against chew-
ing lice, and also aids in the control and treatment 
of Sarcoptic mange. Recently, the oral chewable 
afoxolaner (NexGard®, Merial) was marketed with 
one month kill efficacy against fleas (C. felis) and 
ticks (R. sanguineus, D. variabilis, I. scapularis, 
and A. americanum). This randomised controlled 
comparative laboratory study was designed to dem-
onstrate the residual speed of efficacy of Seresto® 
for the control of ticks (D. variabilis and A. ameri-
canum) at 6 and 12 hours post-infestation on dogs 
when compared to 2 competitive products and a 




Dogs were included if they were over 6 months of 
age, determined to be healthy based on physical 
examination, not pregnant, were able to harbor an 
adequate tick infestation, and were not exposed to 
a previous insecticide/acaracide within 90 days of 
study onset. Initially, 48 dogs were evaluated for 
inclusion in the study. The dogs were evaluated 
for the ability to harbor adequate tick infestations. 
Briefly, 48 dogs were each infested with approxi-
mately 50 D. variabilis on study day –7. On study 
day -5, tick counts were performed to remove all 
live ticks. Dogs were then ranked by pre-study live 
tick counts in descending order and randomised 
in sets of 4, excluding 8  dogs with the lowest 
tick counts. The results from 3 groups of 10 ani-
mals, Group 1) Seresto®, Group 2) NexGard®, and 
Group 3) non-treated controls, are reported here. 
The fourth group, fluralaner (Bravecto®, Merck), 
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along with dogs in Groups 1 and 3 are presented 
in a separate manuscript.
Products 
Both products were administered in accordance 
with the manufacture’s guidelines and according to 
the weight of each dog prior to treatment. On study 
day 0, Group 1 dogs had Seresto® collars contain-
ing imidacloprid 10 % (w/w) / flumethrin 4.5 % (w/w) 
applied around the neck. The length was adapted 
to fit the dog according to label directions with the 
extra length cut off and secured with a ratchet 
mechanism. Collars were applied according to the 
dog’s bodyweight (collar dose ranges: small col-
lar < 18 lbs, large collar > 18 lbs). Group 2 dogs were 
treated orally with NexGard® (afoxolaner) at a dos-
age of 3.1 – 6.2 mg/kg. Two size chews were avail-
able and dosed based on body weight: 28.3 mg and 
68 mg. The control group remained non-treated. 
Experimental infestations
Dogs were infested with D. variabilis and A. ameri-
canum based on a predetermined schedule. Each 
infestation consisted of approximately 50 ticks of 
each species applied along the dog’s dorsal midline 
from shoulders to hips. 
Experimental design
This laboratory study was conducted in accordance 
with VICH GL9 Good Clinical Practices (GCP), 
June 2000 (FDA Guidance for Industry 85, May 
2001) and applicable standard operating procedu-
res. Dogs were individually housed in runs for the 
duration of the study. They were bathed with a 
mild, non-medicated shampoo, thoroughly combed, 
and allowed to acclimate for 11 days prior to the 
initiation of treatments. Concomitant treatments 
were prohibited, except where deemed necessary 
and would not influence the performance of any 
product. 
Following product administration, each dog was 
infested with 50 D. variabilis and 50 A. americanum 
on study days 3, 14, 21, and 28. Tick counts were 
performed at 6 hours (thumb count) and 12 hours 
(full body comb count with tick removal) following 
infestation to assess the speed of repellency and/or 
kill; all ticks on the dogs were counted including 
live (attached and non-attached) and dead attached 
ticks.
Clinical monitoring
The dogs were observed at least once daily during 
the acclimation period and a physical examination 
was performed on each dog prior to starting the 
study to verify the health status. For the remainder 
of the study, dogs were observed daily until study 
completion, at which time dogs were returned 
to the supplier. On study day 0, dogs were also 
observed 2 and 4 hours after product administra-
tion for adverse events. 
Efficacy determination
Total live (attached and non-attached) and dead 
attached tick counts were determined and recorded. 
Individual live tick counts were used to calculate a 
geometric mean (GM) for each group at each time 
point on the specified study days. For each post-
treatment tick count, efficacy was calculated using 
Abbott’s Formula. Percent efficacy (% reduction) 
was determined by comparing the GM number of 
live ticks retained on the treated group to the GM 
number of live ticks retained on the non-treated 
negative control group using the following formula:
 
 % efficacy =
GM tick count control − GM tick count (treatment)
GM tick count(control)
Data analysis
For D. variabilis, the assumption of equally distrib-
uted tick-ridding ability was assessed by descrip-
tively summarising the pre-study tick counts. The 
statistical method comparing post-treatment tick 
counts utilised the pre-study tick counts for each 
animal. The efficacy of the treated groups, relative 
to the control group, was computed with Abbott’s 
formula. Arithmetic mean counts and geometric 
means were both used in the efficacy calculation. 
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Geometric means were calculated following trans-
formation using a logarithmic method (averaging 
the transformed values, and converting the aver-
age using antilog to represent a geometric mean). 
Because some animals might have had zero (0) tick 
counts, all counts were modified by adding one (1) 
to each prior to logarithmic transformation. Also, 
one (1) was subtracted from the antilog value to 
meaningfully represent the geometric mean for 
each group. Only live tick counts were used to cal-
culate efficacy.
Live, dead and total (total live and dead attached) 
tick counts for each species were analysed 
separately. Log (tick counts+1) were analysed 
with a repeated measures analysis of covariance 
(RMANCOVA) including terms for treatment 
(TRT), animal (random), study day (DAY), and 
the interaction of treatment and study day (TRT 
x DAY), using the pre-treatment tick counts as 
a covariate (for D. variabilis only, no baseline 
covariate when analysing for the other tick spe-
cies). SAS PROC MIXED (SAS® Institute, Cary, 
NC) was used for analysis with the covariance 
structures ‘AR(1)’ and ‘ARH(1)’ for data collect-
ed on equal intervals, or ‘CS’ and ‘CSH’ for data 
collected on unequal intervals. Results from the 
Table 1  Dermacentor variabilis efficacy and geometric mean live (attached and non-attached), dead attached, and total 
(total live and dead attached) tick counts after treatment with Seresto® or NexGard® 
Study Day Day 3 Day 14 Day 21 Day28
Hours  
post-infestation
6h 12h 6h 12h 6h 12h 6h 12h
Seresto® 
Mean # live 1.5b 1.0b 0.0b 0.0b 0.2b 0.0b 0.1b 0.1b
Mean # dead 
attached
0.1a 1.1ab 0.8a 0.5a 0.3a 0.5a 0.2a 0.2a
Mean # total 1.6b 2.1b 0.8b 0.5b 0.4b 0.5b 0.2b 0.2b
% Efficacyc 94.9 97.0 100 100 99.0 100 99.7 99.8
NexGard®
Mean # live 16.0a 14.1a 11.6a 17.9a 10.2a 17.3a 12.9a 21.6a 
Mean # dead 
attached
0.4a 2.7b 0.3a 1.8a 0.4a 1.1a 0.0a 0.4a 
Mean # total 16.6a 20.2a 11.9a 21.4a 10.5a 19.2a 12.9a 22.0a 
% Efficacyc 43.7 59.3 38.5 38.6 48.4 40.4 38.5 27.2
Control
Mean # live 28.5a 34.6a 18.9a 29.2a 19.8a 29.0a 20.9a 29.6a
Mean # dead 
attached
0.0a 0.0a 0.2a 0.0a 0.0a 0.0a 0.0a 0.0a
Mean # total 28.5a 34.6a 19.3a 29.2a 19.8a 29.0a 20.9a 29.6a
a,b  Values down columns with unlike superscripts are significantly different (p <  0.05)
c %  Efficacy calculated using Abbott’s Formula
Note: Geometric Mean # totals are not expected to equal the sum of geometric mean # live + geometric mean # dead 
attached due to the mathematical basis for calculating geometric means.
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model with the smallest Akaike’s Information 
Criterion were used. 
If the interaction of treatment and study day 
was significant at the 0.05 level, multiple group 
pairwise comparisons were generated using a 
Bonferroni alpha adjustment for multiple group 
comparisons. These simple effect pairwise com-
parisons were obtained from the TRT x DAY inter-
action. If the interaction term was not significant 
(p > 0.05), the TRT main effect was evaluated. If 
the TRT main effect was not significant (p > 0.05), 
the results were deemed not significant and no 
further analyses were conducted. If the TRT main 
effect was significant (p ≤ 0.05), multiple group 
pairwise comparisons were generated using a 
Bonferroni alpha adjustment for multiple group 
comparisons across the pooled time points. In 
addition, dead attached ticks and total ticks were 
compared across groups. However, pre-treatment 
D. variabilis counts were not used as a covari-
ant when dead attached or total ticks were ana-
lyzed. All four treatment groups were analysed 
together, however only the results from Groups 
1, 2 and 3 are reported here. Software from SAS® 
Institute, Cary, NC version 9.3 was used for all 
analyses.
Table 2  Amblyomma americanum efficacy and geometric mean live (attached and non-attached), dead attached, and 
total (total live and dead attached) tick counts after treatment with Seresto® or NexGard® 
Study Day Day 3 Day 14 Day 21 Day28
Hours  
post-infestation
6h 12h 6h 12h 6h 12h 6h 12h
Seresto®
Mean # live 0.7b 0.2b 0.0b 0.0b 0.1b 0.1b 0.1b 0.0b
Mean # dead 
attached
0.2a 0.7ab 1.1a 0.7a 0.7a 0.4ab 0.3a 0.3a
Mean # total 1.0b 0.9b 1.1b 0.7b 0.7b 0.4b 0.4b 0.3b
% Efficacyc 94.2 98.4 100 100 99.6 99.7 99.5 100
NexGard®
Mean # live 12.4a 9.8a 7.5a 9.6a 12.1a 15.1a 12.3a 13.1a
Mean # dead 
attached
0.1a 2.9b 0.5a 1.1a 0.3a 2.1b 0.0a 1.1a
Mean # total 12.6a 13.9a 8.1a 11.0a 12.7a 18.7a 12.3a 15.0a
% Efficacyc -1.7 31.6 12.6 0.8 37.6 35.4 18.5 40.0
Control
Mean # live 12.2a 14.4a 8.6a 9.6a 19.4a 23.4a 15.1a 21.8a
Mean # dead 
attached
0.0a 0.0a 0.1a 0.0a 0.0a 0.0a 0.0a 0.0a
Mean # total 12.2a 14.4a 8.8a 9.6a 19.4a 23.4a 15.1a 21.8a
a,b  Values down columns with unlike superscripts are significantly different (p < 0.05)
c  % Efficacy calculated using Abbott’s Formula 
Note: Geometric Mean # totals are not expected to equal the sum of geometric mean # live + geometric mean # dead 




Thirty dogs (16 females and 14 males) were 
included in Groups 1, 2 and 3. All dogs were 
over 6 months of age and ranged in weight from 
6.5 – 15.3kg. Dogs were dosed according to the label 
directions. In Group 1, there was 1 dog treated with 
the small dog Seresto® collar (< 18 lbs) and 9 dogs 
were treated with the large dog collar (> 18 lbs). 
In Group 2, the dose ranged from 3.1 – 6.2 mg/kg. 
There were no adverse events during the study. 
Efficacy against D. variabilis at 6 hours for Group 1 
Fig. 1  Efficacy 6 hours post-infestation with D. variabilis after treatment with Seresto® or NexGard®
*  Live tick counts significantly different (p < 0.05) as compared NexGard® and control group
a % Efficacy calculated using Abbott’s Formula 
Fig. 2  Efficacy 12 hours post-infestation with D. variabilis after treatment with Seresto® or NexGard®
*  Live tick counts significantly different (p < 0.05) as compared to NexGard® and control group
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was 95 – 100 % and for Group  2 was 38 – 48 % 
(Table 1, Fig. 1); efficacy at 12 hours for Group 1 
was 97 – 100 % and for Group  2 was 27 – 59 % 
(Table 1; Fig. 2). Efficacy against A. americanum 
at 6 hours for Group  1 was 94 – 100 % and for 
Group 2 was  < 0 – 38 % (Table 2; Fig. 3); efficacy 
at 12 hours for Group 1 was 98 – 100 % and for 
Group 2 was 1 – 40 % (Table 2; Fig. 4). The major-
ity (average > 87 % for both species) of live ticks on 
the NexGard treated dogs at 6 hours post-infesta-
tion were attached to the dogs and not loose on the 
body; at 12 hours, an average of > 99 % of live ticks 
Fig. 3  Efficacy 6 hours post-infestation with A. americanum after treatment with Seresto® or NexGard®
*  Live tick counts significantly different (p < 0.05) as compared to NexGard® and control group
a  % Efficacy calculated using Abbott’s Formula 
Fig. 4  Efficacy 12 hours post-infestation with A. americanum after treatment with Seresto® or NexGard®
*  Live tick counts significantly different (p < 0.05) as compared to NexGard® and control group
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Fig. 5 Dermacentor variabilis 6 hour geometric mean live (attached and non-attached) and dead attached tick counts 
after treatment with Seresto® or NexGard®
* Total tick counts significantly different (p < 0.05) as compared to NexGard® and control group
Note: Geometric Mean # totals are not expected to equal the sum of geometric mean # live + geometric mean # dead 






























Fig. 6 Dermacentor variabilis 12 hour geometric mean live (attached and non-attached) and dead attached tick counts 
after treatment with Seresto® or NexGard®
* Total tick counts significantly different (p < 0.05) as compared to NexGard® and control group
Note: Geometric Mean # totals are not expected to equal the sum of geometric mean # live + geometric mean # dead 
































on NexGard dogs were attached and feeding. Live 
(attached and non-attached) and total (total live 
and dead attached) tick counts in Group 1 against 
both tick species were significantly lower (p ≤ 0.05) 
than Group 2 at both 6 and 12 hours post-infesta-
tion on all challenge days. Also, there were signifi-
cantly fewer (p ≤ 0.05) live and total ticks of both 
species on Group 1 dogs compared to Group 3 (con-
trol) dogs at all time points (Table 1 – 2, Fig. 5 – 8); 
the number of live or total ticks on Group 2 dogs 
were never significantly lower when compared to 
the respective number of ticks on Group 3 dogs. 
When the two species were combined (sum total of 
average of D. variabilis and A. americanum), total 
tick counts in Group 1 were at most only 3.0 ticks/
dog, whereas Group 2 reached 37.9 ticks/dog, and 
Group 3 reached 52.4 ticks/dog.
Discussion
Ticks are prevalent throughout the world, trans-
mit more pathogenic organisms than any other 
arthropod, and compete with mosquitoes as being 
the most important vector of diseases affecting 
dogs, livestock, and humans (Dantas-Torres et al. 
2012; Jongejan and Uilenberg 2004). The incidence 
of tick-borne diseases in humans and animals is 
increasing worldwide as the spread of ticks into 
new areas continues and enhanced molecular 
biology techniques have identified new species, 
strains, and genetic variations of microorganisms 
further increasing the number of tick-borne dis-
eases (Duh et al. 2010; Gray et al. 2009; Jongejan 
and Uilenberg 2004; Nicholson et al. 2010; Pacheco 
et al. 2011; Paddock and Childs 2003; Savage et al. 
2013). A study published in 2014, which evaluated 
dogs in the United States, reported a mean preva-
lence of 7.2 % (509,195/6,996,197) for B. burgdor-
feri, 1.6 % (111,673/6,994,683) for E. canis, and 
4.4 % (270,168/6,192,268) for Anaplasma phagocy-
tophilum (Little et al. 2014). In comparison to a 
previous report in 2009, the prevalence of dogs with 
antibodies to B. burgdorferi and E. canis increased 
from 5.1 % and 0.6 % respectively; the prevalence of 
A. phagocytophilum decreased slightly from 4.8 % 
(Bowman et al. 2009).
Due to the potentially severe clinical implications 
of fleas, ticks, and the pathogens they can vec-
tor, products should be administered to dogs and 
cats year-round (Baneth et al. 2012; CAPC 2011). 
Furthermore, to aid in the prevention of pathogen 
transmission, a product should ideally prevent 
ticks from attaching and feeding (Spencer et al. 
2003). If repellency is not possible, a product must 
exert its anti-feeding/kill effects quickly, before 
transmission can occur (Blagburn et al. 2004; Spen-
cer et al. 2003). Guidelines from the 2011 Canine 
Vector-Borne Disease (CVBD) world forum recom-
mend prevention as the best approach to inhibit 
transmission of disease causing organisms with 
3 specific strategies (Baneth et al. 2012). First, as 
pathogen transmission can occur almost immedi-
ately from most vectors and some ticks, a product 
with repellent properties should be considered to 
avoid blood feeding by arthropods. Second, animals 
should be protected from as many parasites as possi-
ble. Finally, year-round flea and tick control should 
be maintained. In 2006, a Lyme disease consensus 
statement by the American College of Veterinary 
Internal Medicine (ACVIM) further emphasized 
the importance of repellency, especially for rapidly 
transmitted diseases, and stated that “any of these 
[permethrin/imidacloprid, fipronil, amitraz collar, 
and other permethrin-containing products] prod-
ucts can be effective in reducing transmission of 
Bb [B. burgdorferi] to dogs. However, products that 
prevent tick attachment or repel ticks are needed 
to decrease transmission of other tick-borne infec-
tions” (Littman et al. 2006).
Seresto® is a uniquely formulated collar and one of 
the few products available that not only kills but 
also repels fleas and ticks on dogs and cats. Recent 
research supports the conclusions by the CVBD 
forum and the ACVIM consensus statement that 
products with repellent properties are important to 
aid in the prevention of vector-borne disease trans-
mission. Specifically, Seresto® has been shown to 
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Fig. 7 Amblyomma americanum 6 hour geometric mean live (attached and non-attached) and dead attached tick 
counts after treatment with Seresto® or NexGard®
* Total tick counts significantly different (p < 0.05) as compared to NexGard® and control group
Note: Geometric Mean # totals are not expected to equal the sum of geometric mean # live + geometric mean # dead 






























Fig. 8 Amblyomma americanum 12 hour geometric mean live (attached and non-attached) and dead attached tick 
counts after treatment with Seresto® or NexGard®
* Total tick counts significantly different (p < 0.05) as compared to NexGard® and control group
Note: Geometric Mean # totals are not expected to equal the sum of geometric mean # live + geometric mean # dead 
































aid in the prevention of E. canis, Babesia canis, 
Babesia vogeli, and Anaplasma platys transmis-
sion in dogs and Cytauxzoon felis transmission 
in cats (Dantas-Torres et al. 2013; Fourie et al. 
2013a; Reichard et al. 2013; Stanneck et al. 2012). 
Seresto® also aided in the prevention of Bartonella 
helselae transmission by C. felis and Leishmania 
infantum transmission by sand flies (Brianti et al. 
2014; Lappin et al. 2013; Otranto et al. 2013).
In this study, Seresto® was highly efficacious 
(94 – 100 %) at repelling and killing D. variabilis 
and A. americanum ticks as soon as 6 hours post-
infestation starting 3 days after application. The 
results illustrate the rapid repellent properties 
of the product by inhibiting almost all ticks from 
attaching and feeding within 6 hours of infesta-
tion. Ticks that are repelled and killed are unable 
to attach and feed, therefore decreasing the risk of 
disease causing organism transmission, as exempli-
fied in the aforementioned studies. In the authors’ 
clinical experience, these same repellent proper-
ties are observed after placing ticks on Seresto® 
treated dogs. Ticks appear uncomfortable and irri-
tated almost immediately, crawling aimlessly on 
the haircoat until they fall off of the dog and are 
killed. This irritant action is further characterised 
in the World Association for the Advancement 
of Veterinary Parasitology (WAAVP) guidelines 
(Marchiondo et al. 2013). Sensu stricto repellency 
is characterised, according to the WAAVP, by ticks 
that are found either moving away from the treated 
animal or that fall off within 6 – 8 hours after con-
tact with treated haircoat, both characteristics of 
ticks applied to Seresto® treated dogs.
In contrast to Seresto®, the number of ticks on Nex-
Gard® treated dogs was never statistically differ-
ent from non-treated control dogs throughout the 
study. Out of the 50 ticks of each species applied 
to the dogs, the geometric mean live tick counts on 
NexGard® treated dogs were up to 21.6 D. variabilis 
and 15.1 A. americanum ticks. This is in comparison 
to Seresto® treated dogs with up to 1.5 live D. vari-
abilis and 0.7 live A. americanum ticks. Even at 
12 hours, most of the ticks attached to the NexGard® 
treated dogs were still alive and feeding. If infect-
ed, these ticks would have the potential to transmit 
pathogens. Similar efficacy results for NexGard® 
were reported in dogs infested with Ixodes ricinus 
ticks, a species not found in North America (Halos 
et al. 2014). In that study, the 12 hour efficacy the 
day of treatment was high (93.4 %) but rapidly 
declined over the month to 76.6 %, 41.9 %, 36.9 %, 
and 38.5 % on days 7, 14, 21, and 28 respectively. 
It should be noted that the WAAVP guidelines sug-
gest that tick efficacy be determined 48 hours after 
an infestation and in rare cases, efficacy may be 
determined at 72 hours (systemic products or when 
taking into account the potential transmission of 
pathogens) (Marchiondo et al. 2013). Therefore, 
despite the fact that pathogens can be transmitted 
within these long time periods, the purpose of this 
study was not to discredit the actual label claims 
for NexGard®. The purpose was to determine the 
speed of repellency and/or kill of both products. 
Further studies should be performed to determine 
the effect of NexGard® treatment on preventing 
transmission of disease causing organisms. 
Conclusion
In this study, Seresto® (imidacloprid/flumethrin 
collar) was highly efficacious (94 – 100 %) at killing 
D. variabilis and A. americanum ticks on dogs at 
6 and 12 hours post-infestation and was signifi-
cantly more efficacious (p ≤ 0.05 based on live tick 
counts) than NexGard® (afoxolaner) on all chal-
lenge days. The efficacy of NexGard® was never sig-
nificantly different from non-treated control dogs 
(p > 0.05 based on live tick counts). There were also 
significantly fewer total ticks (sum of live attached, 
live non-attached, and dead attached) of each spe-
cies (p ≤ 0.05) on dogs treated with Seresto® com-
pared to dogs treated with NexGard® at all time 
points. The results of this study support the rapid 
repel and kill properties of Seresto® that are impor-
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